JP2008540618A5 - - Google Patents

Download PDF

Info

Publication number
JP2008540618A5
JP2008540618A5 JP2008511739A JP2008511739A JP2008540618A5 JP 2008540618 A5 JP2008540618 A5 JP 2008540618A5 JP 2008511739 A JP2008511739 A JP 2008511739A JP 2008511739 A JP2008511739 A JP 2008511739A JP 2008540618 A5 JP2008540618 A5 JP 2008540618A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
amide
sulfonic acid
methylnaphthalene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008511739A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008540618A (ja
Filing date
Publication date
Priority claimed from FI20055235A external-priority patent/FI20055235A0/fi
Application filed filed Critical
Priority claimed from PCT/FI2006/050197 external-priority patent/WO2006123020A1/en
Publication of JP2008540618A publication Critical patent/JP2008540618A/ja
Publication of JP2008540618A5 publication Critical patent/JP2008540618A5/ja
Pending legal-status Critical Current

Links

JP2008511739A 2005-05-18 2006-05-16 ソマトスタチン受容体サブタイプ1及び/又は4に選択的なペプチド模倣薬 Pending JP2008540618A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68202005P 2005-05-18 2005-05-18
FI20055235A FI20055235A0 (fi) 2005-05-18 2005-05-18 Somatostatiinireseptorialatyyppeihin 1 ja/tai 4 selektiivisesti vaikuttavat peptidienkaltaiset yhdisteet
PCT/FI2006/050197 WO2006123020A1 (en) 2005-05-18 2006-05-16 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4

Publications (2)

Publication Number Publication Date
JP2008540618A JP2008540618A (ja) 2008-11-20
JP2008540618A5 true JP2008540618A5 (https=) 2009-07-02

Family

ID=37430963

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008511739A Pending JP2008540618A (ja) 2005-05-18 2006-05-16 ソマトスタチン受容体サブタイプ1及び/又は4に選択的なペプチド模倣薬

Country Status (5)

Country Link
US (1) US20100048549A1 (https=)
EP (1) EP1885693A4 (https=)
JP (1) JP2008540618A (https=)
CA (1) CA2609161A1 (https=)
WO (1) WO2006123020A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103382174A (zh) 2006-06-23 2013-11-06 雅培制药有限公司 作为组胺h3受体调节物的环丙胺衍生物
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
US8853390B2 (en) 2010-09-16 2014-10-07 Abbvie Inc. Processes for preparing 1,2-substituted cyclopropyl derivatives
EP3371149A4 (en) * 2015-11-04 2019-03-20 University of Florida Research Foundation, Inc. POLYAMINE SULFONAMIDES AND USES THEREOF
CN114949174B (zh) * 2022-07-19 2025-09-30 山东大学齐鲁医院 Cst-14在制备糖尿病皮肤溃疡、破损治疗药物中的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485101A (en) * 1983-10-11 1984-11-27 Administrators Of The Tulane Educational Fund Peptides
US5409894A (en) * 1991-03-14 1995-04-25 Sandoz Ltd. Method of preventing balloon catheterization blood vessel damage
JPH069402A (ja) * 1991-05-15 1994-01-18 Hiroyoshi Hidaka 抗潰瘍剤
FR2689130B1 (fr) * 1992-03-30 1994-05-27 Synthelabo Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique.
US5248673A (en) * 1992-12-23 1993-09-28 Bristol-Myers Squibb Co. Bisamidine derivatives as thrombin inhibitors
KR0173034B1 (ko) * 1995-04-28 1999-03-30 성재갑 선택적 트롬빈 억제제
WO1997029097A1 (en) * 1996-02-09 1997-08-14 Smithkline Beecham Plc Sulfonamide derivatives as 5ht7 receptor antagonists
DE69832376T2 (de) * 1997-04-21 2006-08-03 Takeda Pharmaceutical Co. Ltd. 4,1-benzoxazepine, ihre analoga, und ihre verwendung als somatostatin-agonisten
GB9711043D0 (en) * 1997-05-29 1997-07-23 Ciba Geigy Ag Organic compounds
US6124256A (en) * 1998-03-27 2000-09-26 Haeyry; Pekka Method for the prevention of a patient's fibroproliferative vasculopathy
EP1070054A1 (en) * 1998-04-08 2001-01-24 Takeda Chemical Industries, Ltd. Amine compounds, their production and their use as somatostatin receptor antagonists or agonists
FR2800735B1 (fr) * 1999-11-09 2002-02-01 Centre Nat Rech Scient Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation
GB0013060D0 (en) * 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
JP2005535710A (ja) * 2002-08-09 2005-11-24 トランス テック ファーマ,インコーポレイテッド アリールおよびヘテロアリール化合物ならびに凝固を調節する方法
GB0314476D0 (en) * 2003-06-20 2003-07-23 Glaxo Group Ltd Compounds
FI20031454A0 (fi) * 2003-10-06 2003-10-06 Juvantia Pharma Ltd Oy Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja
WO2005033068A1 (en) * 2003-10-06 2005-04-14 Oy Juvantia Pharma Ltd Somatostatin receptor 1 and/or 4 selective agonists and antagonists
FI20031455A0 (fi) * 2003-10-06 2003-10-06 Juvantia Pharma Ltd Oy Sulfonyyliamino-peptidomimeettejä, jotka ovat aktiivisia somatostatiinireseptorialatyyppien 4 (SSTR4) ja 1 (SSTR1) suhteen
JP4521531B2 (ja) * 2004-07-01 2010-08-11 財団法人名古屋産業科学研究所 不斉アシル化触媒及び光学分割方法

Similar Documents

Publication Publication Date Title
JP5453312B2 (ja) アルファ2bおよび/またはアルファ2cアドレナリンレセプターのサブタイプ選択性モジュレーターである置換アリール‐(イミダゾール)‐メチル)‐フェニル化合物
US6734203B2 (en) Fused imidazolium derivatives
RU2325382C2 (ru) Производные 1h-1,2,4-триазол-3-карбоксамида в качестве лигандов рецептора каннабиноидов
JP6795517B2 (ja) 5−芳香族アルキニル基置換ベンズアミド系化合物並びにその製造方法、薬物組成物及び使用
WO2018231745A1 (en) Compounds for modulating s1p1 activity and methods of using the same
WO2009089132A1 (en) Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
HRP20161306T1 (hr) Dimerni spojevi kao agonisti receptora fgf (fgfr), postupak za njihovu pripravu i njihova terapijska uporaba
TWI226240B (en) Piperazine compound
CN102548988B (zh) 阿齐沙坦有机胺盐及其制备方法和用途
JP2013508384A (ja) アルファアドレナリン受容体モジュレーター
CA2603044A1 (en) Alpha-2 adrenergic agonists for the treatment of pain
JP2011506463A5 (https=)
JP2008540618A5 (https=)
JP6693520B2 (ja) ピペラジン誘導体
DK2932968T3 (en) CONNECTION TO TREATMENT OF ALFA-ADRENERG MEDIED CONDITIONS
JP2007507473A5 (https=)
JP2008514601A (ja) 特異的α2アドレナリン作動剤としての4−(フェニルメチルおよび置換フェニルメチル)−イミダゾール−2−チオン
WO2016132296A1 (en) A process for the preparation of an intermediate of dabigatran etexilate
JP4168086B1 (ja) イミダゾリン誘導体
JP5480819B2 (ja) 選択的サブタイプアルファ2アドレナリンアゴニスト及びその使用方法
EP1885693A1 (en) Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
JP2011510013A (ja) 選択的サブタイプアルファ2アドレナリンアゴニスト及びその使用方法
JP6031719B2 (ja) アルファ2アドレナリン作動性受容体のモジュレーターとしてのn−(イミダゾリジン−2−イリデン)キノリン誘導体
KR20060125862A (ko) 심방 수축력의 선택적 증가 및 심부전증 치료를 위한Kv1.5-차단제
CN101003520A (zh) 一种缬氨酸丁酰联苯化合物